drugset / Trial / NCT00003445

Docetaxel in Treating Patients With Advanced Cancer of the Cervix

NCT00003445 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients with advanced cancer of the cervix.

Timeline

Start
1997-12
Primary completion
—
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule — Intravenous

Indications